Stocks and Investing Stocks and Investing
Thu, January 30, 2025
[ Last Thursday ] - WOPRAI
As of Jan 30th, 2025, there has been substantial .. g of Echo Defense Projects Inc. in recent trading
[ Last Thursday ] - WOPRAI
As of Jan 30th, 2025, there has been substantial selling of BioAdaptives, Inc. in recent trading
[ Last Thursday ] - WOPRAI
As of Jan 30th, 2025, there has been substantial selling of Tapinator, Inc. in recent trading
[ Last Thursday ] - WOPRAI
As of Jan 30th, 2025, there has been substantial .. hnology Venture Company Limited in recent trading
[ Last Thursday ] - WOPRAI
As of Jan 30th, 2025, there has been substantial .. lling of Alpha Tau Medical Ltd. in recent trading
[ Last Thursday ] - WOPRAI
As of Jan 30th, 2025, there has been substantial .. hium Resource & Technology Ltd. in recent trading
[ Last Thursday ] - WOPRAI
As of Jan 30th, 2025, there has been substantial .. of NeuroSense Therapeutics Ltd. in recent trading
[ Last Thursday ] - WOPRAI
As of Jan 30th, 2025, there has been substantial selling of in recent trading
[ Last Thursday ] - Investopedia
Is Warren Buffett Right That the Stock Market Is Like a Casino? What Investors Need To Know
Wed, January 29, 2025
[ Last Wednesday ] - MSN
International Paper Company (IP): Investing in Renewable Packaging Innovation
[ Last Wednesday ] - MSN
UPS's SWOT analysis: global logistics giant navigates shifting stock landscape
[ Last Wednesday ] - MSN
DeepSeek and AI's Efficiency Era
[ Last Wednesday ] - MSN
Why Novo Nordisk A/S (NVO) Is the Best Blue Chip Stock to Buy Under $100?
[ Last Wednesday ] - MSN
Looking for a bargain? 4 ways to tell if a stock is undervalued
[ Last Wednesday ] - MSN
Investing Lessons from Mark Cuban Anyone Can Use
[ Last Wednesday ] - Kiplinger
Stock Market Today: Stocks Jump Around on Fed Day
[ Last Wednesday ] - AOL
3 ETFs Every Baby Boomer Should Buy and Hold Forever
[ Last Wednesday ] - WOPRAI
Short squeeze is starting in shares of MONI at $0 .. 17, after crossing above the $0.017 Trigger Price
[ Last Wednesday ] - WOPRAI
Short squeeze is starting in shares of STKL at $7 .. 45, after crossing above the $7.496 Trigger Price
[ Last Wednesday ] - MSN
US stocks, Nvidia shares steady after Chinese AI shock
[ Last Wednesday ] - WOPRAI
Short squeeze is starting in shares of TMQ at $1.29, after crossing above the $1.273 Trigger Price
[ Last Wednesday ] - WOPRAI
Short squeeze is starting in shares of PRMO at $0 .. 04, after crossing above the $0.001 Trigger Price
[ Last Wednesday ] - WOPRAI
Short squeeze is starting in shares of PPCB at $25, after crossing above the $0.003 Trigger Price
[ Last Wednesday ] - MSN
Retire Rich With 2 Resilient Growth Stocks
[ Last Wednesday ] - Kiplinger
ASML Stock Remains a Strong Buy After Earnings
[ Last Wednesday ] - WOPRAI
Short squeeze is starting in shares of SNPMF at $ .. 57, after crossing above the $0.569 Trigger Price
[ Last Wednesday ] - WOPRAI
Short squeeze is starting in shares of WKSP at $1.1, after crossing above the $1.077 Trigger Price
[ Last Wednesday ] - WOPRAI
Short squeeze is starting in shares of ULCC at $8 .. 25, after crossing above the $8.187 Trigger Price
[ Last Wednesday ] - MSN
5 Building Products Stocks Navigating Industry Challenges
[ Last Wednesday ] - MSN
Cantor Fitzgerald sees upside in select biotech stocks

Cantor Fitzgerald sees upside in select biotech stocks


Published on 2025-01-29 11:41:09 - MSN
  Print publication without navigation

  • In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, Cantor Fitzgerald highlighted a positive outlook despite broader market uncertainties.

The article from MSN Money discusses Cantor Fitzgerald's optimistic outlook on certain biotech stocks, highlighting potential growth opportunities within the sector. The investment firm has identified several biotech companies that they believe are undervalued and poised for significant upside due to upcoming catalysts such as clinical trial results, FDA approvals, and strategic partnerships. The article mentions specific stocks like Sarepta Therapeutics, Alnylam Pharmaceuticals, and Intellia Therapeutics as having strong potential due to their innovative therapies in gene editing and rare disease treatments. Cantor Fitzgerald's analysis suggests that these companies could see substantial stock price increases if their developmental milestones are met, offering investors a chance to capitalize on the biotech sector's volatility and innovation.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/other/cantor-fitzgerald-sees-upside-in-select-biotech-stocks/ar-AA1y4j7H ]
Contributing Sources